RLR. I. Lukashou

R. I. Lukashou

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


R. I. Lukashou has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Calendula Flowers (Calendulae officinalis flos): Methods to Obtain Fractions of Biologically Active Substances

    by R. I. Lukashou, N. S. Gurina

    INTRODUCTION. The pharmaceutical industry aims at developing sustainable resource-saving technologies for manufacturing medicines. Approaches to the effective use of herbal drugs include applying technologies yielding compounds with various pharmacological effects in one production cycle. To date, no standardised herbal drug processing technology has been designed to produce calendula flower-based medicinal products with various pharmacological effects. The Member States of the Eurasian Economic Union (EAEU) process calendula flowers by extraction methods yielding one fraction of biologically active substances per cycle (either only flavonoids or only carotenoids).AIM. This article aimed to investigate the possibility of stepwise processing of calendula flowers to obtain biologically active substances with different polarities (carotenoids, flavonoids, and polysaccharides) per cycle.MATERIALS AND METHODS. The authors extracted carotenoids using hexane. The study included additional thermal pretreatment of the herbal drug. Carotenoids and flavonoids were quantified by spectrophotometry, and polysaccharides were quantified by gravimetric analysis. After hexane removal, the dry oily residue was dissolved in oil with mechanical stirring to obtain the oil extract. The study included a three-step processing method that comprised hexane extraction (extraction of carotenoids with a low-polarity organic solvent), extraction with a water–organic solvent system (extraction of flavonoids), and aqueous extraction (precipitation of polysaccharides).RESULTS. The lipophilic extracts obtained by single hexane extraction or by single hexane extraction and heat treatment had the maximum carotenoid content (~4%), which was 10 times the carotenoid content in the extracts obtained using a water–organic solvent system. Oil extracts were prepared from the dry residue left after removing hexane by distillation at its boiling point. The content of biologically active substances in the oil extracts was comparable to that in the intact herbal drug. Water–organic solvent extraction yielded 68.5% more flavonoids from the herbal drug extracted with hexane than from the intact herbal drug. In contrast, aqueous extraction applied to the intact herbal drug yielded 1.7 times the amount of flavonoids obtained by aqueous extraction preceded by hexane extraction. The water-soluble polysaccharide fraction extracted from the intact herbal drug had 10 times the flavonoid content observed in the fraction extracted from the processed herbal drug. Each subsequent processing step decreased the total polysaccharide content and the content of individual polysaccharide fractions and increased their purity. The ratio of polysaccharide fractions remained unchanged across all processing methods tested.CONCLUSIONS. Stepwise processing of calendula flowers ensured that one processing cycle provided three fractions containing increased amounts of carotenoids, flavonoids, and polysaccharides. Relative to the intact herbal drug, there was a 3.3-fold increase in the yield of carotenoids, and the yields of flavonoids and polysaccharides increased by 44.8 and 41.3%, respectively. The resulting product had a higher degree of purity than the products obtained by pretreatment and double hexane extraction or by using the intact herbal drug. The stepwise processing method is advisable for the production of medicines that are enriched with a specific group of biologically active substances or contain smaller amounts of impurities.


  • Open Access

    Effect of Echinacea purpurea Herb Defatting on the Extraction of Hydroxycinnamic Acids

    by R. I. Lukashou, N. S. Gurina

    INTRODUCTION. Currently the development of novel resourceand cost-effective extraction techniques for herbal medicinal products is a priority for pharmaceutical technology. A unique position among these herbal medicinal products belongs to the medicinal products of Echinacea purpurea, which stimulate the innate immune system.AIM. The study aimed to investigate the effect of E. purpurea herb defatting on the extraction of hydroxycinnamic acids (HCAs) from the herbal drug and to evaluate the suitability of this treatment for the production of E. purpurea tinctures.MATERIALS AND METHODS. On the basis of previous experimental findings, heptane was chosen as the defatting solvent. The production of E. purpurea tinctures included an additional step of herbal drug heating. The content of total HCAs was determined using a pharmacopoeial method, while the content of individual HCAs was determined using high-performance liquid chromatography. The residual defatting solvent was quantified by gas chromatography. The experiment used reference standards for HCAs.RESULTS. The study showed that a single one-hour defatting treatment of the herbal drug with heptane at a 1 g to 5 mL ratio increased the yield of HCAs extracted from Е. purpurea herb. The optimal production process for E. purpurea tinctures involved grinding the herbal drug to 500–2000 μm, macerating the powder with 60% ethanol (v/v) at a 1 g to 10 mL ratio for 7 days, mechanically stirring the mixture for 60 min, and settling the crude extract for 3 days. Heating the herbal drug prior to extraction resulted in the highest yield of HCAs.CONCLUSIONS. The newly developed production technology for E. purpurea tinctures with a preliminary defatting step increases the HCA content in the tinctures. This technology can be used for the industrial production of tinctures high in HCAs.


  • Open Access

    Antimicrobial and Antioxidant Activity Screening of Mushrooms Growing in the Leningrad Region

    by A. O. Whaley, V. V. Novikova, V. O. Vasiliev, A. V. Klemper, R. I. Lukashov, N. I. Mandrik, N. S. Gurina, G. P. Yakovlev, V. G. Luzhanin

    Introduction. The emergence of new strains of microorganisms that are multidrug resistant (MDR) in relation to the antimicrobial drugs used is one of the pressing problems of modern medicine. To prevent an increase in MDR-related deaths, the search for new antibiotics and their introduction into medical practice must be continuously ongoing. Infectious diseases are also accompanied by cell damage and the development of free radical oxidation processes, therefore the search for new antioxidants is also an important task. Considering the powerful biosynthetic potential of basidiomycetes, this group of fungi has every prospect of becoming a new source of biologically active substances in general, as well as antibiotics and antioxidants in particular. Cap mushrooms, represented mainly by basidiomycetes, number about 14,000 species and are an accessible source of raw materials for the search for promising antimicrobial compounds and antioxidants.Aim. Study of the antioxidant and antimicrobial activity of total extracts obtained from cap mushrooms against Escherichia coli, Staphylococcus aureus and Candida albicans and assessment of the suitability of cap mushrooms as a natural source of substances with antimicrobial and antioxidant activity.Materials and methods. The antifungal and antibacterial activity of the extracts was determined by the micromethod of two-fold serial dilutions in a liquid nutrient medium in 96-well plates in duplicate. The study of this type of biological activity was carried out against reference (type) strains Staphylococcus aureus ATCC 6538-P, Escherichia coli ATCC 25922, Candida albicans NCTC 885-653. To study antioxidant activity using DPPH, we used alcoholic extracts from the fruiting bodies of mushrooms obtained by maceration with 96 % ethanol at a ratio of raw materials to extractant of 1 to 8 for 24 hours, an aqueous solution of ascorbic acid (vitamin C) and an ethanol solution of Trolox.Result and discussion. In relation to S. aureus, a representative of gram-positive flora, the studied extracts of cap mushrooms showed low activity, on average about 2500 or 5000 μg/ml. In relation to E. coli, a representative of gram-negative flora, 8 % of the studied cap mushroom extracts showed an average activity of about 1250 μg/ml. The largest number of cap mushroom extracts – 19% of all studied species – showed activity against the yeast micromycete C. albicans. The highest activity against C. albicans was observed in extracts of the mushrooms Cantharellula umbonata with an MIC of 625 μg/ml, Cortinarius olivaceofuscus with an MIC of 625 μg/ml, and Hypomyces chrysospermus with an MIC of 312 μg/ml. During screening of antioxidant activity, the studied extracts were divided into three groups: with high (more than 50 % PPR), medium (from 15 to 50 % PPR) and low (less than 15 %) antioxidant activity. It was shown that the sum of phenolic compounds significantly correlates with the level of antioxidant activity in all three groups, but in the groups with medium and low antioxidant activity there are also other non-phenolic groups of compounds that make a significant contribution to the total antioxidant activity.Conclusion. Cap mushrooms are a promising source of biologically active substances with antifungal and antioxidant activity.


  • Open Access

    Flavonoids from Impatiens grandulifera and Their Antioxidant Activity

    by R. I. Lukashov, A. O. Whaley, E. V. Zhokhova, N. S. Gurina, M. U. Goncharov, G. P. Yakovlev, V. A. Tsiarletskaya

    Introduction. The genus Impatiens L. includes about 850 species, which are found mainly in tropical and subtropical climate zones. The Indigenous people of Pakistan used pastes and extracts from I. glandulifera for the treatment of joint pain, anxiety and skin allergies [6]. Flowers of I. glandulifera are used in Bach flower remedies, which are used for sedation, relaxation and helping to balance emotional states.Aim. Isolation and structural elucidation of 11 phenolic constituents from the aerial parts of I. glandulifera and the evaluation of their antioxidant activity.Materials and methods. The aerial part of Impatiens glandulifera Royle was collected in the Leningrad region near the village of Orekhovo in 2021. Fractions were analyzed by analytical high performance liquid chromatography (HPLC) using a Prominence LC-20 (Shimadzu, Japan) equipped with a diode array detector. The isolation of individual compounds was carried out by column chromatography on open glass columns with sorbents of different selectivity, as well as by preparative HPLC using a Smartlina (Knauer, Germany) equipped with a spectrophotometric detector. The structure of isolated individual compounds was established by 1D and 2D NMR spectroscopy (Bruker Avance III 400 MHz, Germany). To study the antioxidant activity, we used solutions obtained by dissolving the isolated substances in a mixture of dimethyl sulfoxide and ethanol; an aqueous solution of vitamin C and an alcoholic solution of Trolox (Sigma-Aldrich, Japan).Result and discussion. Phytochemical analysis of the aerial parts of Impatiens glandulifera Royle. resulted in the isolation of 11 polyphenolic secondary metabolites (1-11) and their structures were elucidated. The antioxidant activity of all isolated compounds was evaluated.Conclusion. The maximum RAP values of eriodyctiol (3), kaempferol (1), and quercetin (2) did not differ significantly (p = 0.585) from those of the comparator preparations: vitamin C and Trolox, which indicates that the antioxidant effect of these three isolated compounds is comparable to the well-known antioxidants. However, the semi-effective concentrations of these substances are two or more times lower (p = 2.56 · 10–4) comparted with vitamin C.